StockGlow

Pharma Mar, S.A. (PHMMF)

Develops cancer drugs derived from marine organisms.

$90.90+0.06%Healthcare
Compare PHMMF with
StockGlow Score
27
Leaning Bearish
BearishBullish
1 year ago-5.6%

The outlook

PHMMF is trading below both its 50- and 200-day moving averages, positioning it in the lower half of its 52-week range. The stock carries a trailing P/E of 17.3 and shows a bearish lean overall. Analyst coverage appears limited for this European biotech name.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range41% of the way from its 52-week low to high
Market cap
$1.57B
52-wk high
$110.40
52-wk low
$77.41
50-day avg
$92.25
200-day avg
$92.72
Trailing P/E
17.3

Similar stocks

OXBDFOxford Biomedica plc$8.00+0.00%PHGUFPharming Group N.V.$1.18-9.23%GNMSFGenmab A/S$282.00+2.73%SBMFFSino Biopharmaceutical Limited$0.64+1.08%PHM.MCPharma Mar, S.A.$78.70+0.25%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy